BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7881050)

  • 1. Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis.
    You ZB; Pettersson E; Herrera-Marschitz M; Hökfelt T; Terenius L; Nylander I; Goiny M; Hughes J; O'Connor WT; Ungerstedt U
    Neuroreport; 1994 Nov; 5(17):2301-4. PubMed ID: 7881050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
    You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
    You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
    Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain.
    Ge J; Long SK; Kilpatrick IC
    Eur J Pharmacol; 1998 Mar; 345(2):163-70. PubMed ID: 9600632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats.
    You ZB; Herrera-Marschitz M; Nylander I; Goiny M; Kehr J; Ungerstedt U; Terenius L
    Brain Res; 1996 Feb; 710(1-2):241-8. PubMed ID: 8963665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of local cholecystokinin-8 administration on extracellular levels of amino acids and glycolytic products monitored by in vivo microdialysis in the fronto-parietal cortex of the rat.
    Godukhin O; You ZB; Herrera-Marschitz M; Goiny M; Pettersson E; Hökfelt T; Ungerstedt U
    Neurosci Lett; 1995 Jul; 194(1-2):29-32. PubMed ID: 7478205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis.
    You ZB; Saria A; Fischer-Colbrie R; Terenius L; Goiny M; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):717-24. PubMed ID: 8971731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
    You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
    Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices.
    Migaud M; Roques BP; Durieux C
    Neuropharmacology; 1994 Jun; 33(6):737-43. PubMed ID: 7936111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition.
    You ZB; Nylander I; Herrera-Marschitz M; O'Connor WT; Goiny M; Terenius L
    Neuroscience; 1994 Nov; 63(2):415-25. PubMed ID: 7891855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
    Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
    Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis.
    Herrera-Marschitz M; You ZB; Goiny M; Meana JJ; Silveira R; Godukhin OV; Chen Y; Espinoza S; Pettersson E; Loidl CF; Lubec G; Andersson K; Nylander I; Terenius L; Ungerstedt U
    J Neurochem; 1996 Apr; 66(4):1726-35. PubMed ID: 8627331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain.
    Boden PR; Woodruff GN; Pinnock RD
    Br J Pharmacol; 1991 Mar; 102(3):635-8. PubMed ID: 1364831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the origin of striatal cholecystokinin release: studies with in vivo microdialysis.
    You ZB; Herrera-Marschitz M; Brodin E; Meana JJ; Morino P; Hökfelt T; Silveira R; Goiny M; Ungerstedt U
    J Neurochem; 1994 Jan; 62(1):76-85. PubMed ID: 7903356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat.
    Bustamante D; You ZB; Castel MN; Johansson S; Goiny M; Terenius L; Hökfelt T; Herrera-Marschitz M
    J Neurochem; 2002 Nov; 83(3):645-54. PubMed ID: 12390526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas.
    Pérez de la Mora M; Hernandez-Gómez AM; Méndez-Franco J; Fuxe K
    Eur J Pharmacol; 1993 Dec; 250(3):423-30. PubMed ID: 8112402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides.
    You ZB; Herrera-Marschitz M; Terenius L
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1307-15. PubMed ID: 10454508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis.
    Petkova-Kirova P; Rakovska A; Della Corte L; Zaekova G; Radomirov R; Mayer A
    Brain Res Bull; 2008 Sep; 77(2-3):129-35. PubMed ID: 18721670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
    Marshall FH; Barnes S; Pinnock RD; Hughes J
    Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-GABA interactions in rat striatum.
    Rakovska A
    Neuropeptides; 1995 Nov; 29(5):257-62. PubMed ID: 8587661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.